Skip to content

Effects of prenatal docosahexaenoic acid supplementation on offspring cardiometabolic health at 11 years differs by maternal single nucleotide polymorphism rs174602: follow-up of a randomized controlled trial in Mexico.

Randomized controlled trial · Am J Clin Nutr · 2023. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 37839707

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Effects of prenatal docosahexaenoic acid supplementation on offspring cardiometabolic health at 11 years differs by maternal single nucleotide polymorphism rs174602: follow-up of a randomized controlled trial in Mexico.

Wimalasena ST, Ramirez-Silva CI, Gonzalez Casanova I et al.
Am J Clin Nutr · 2023

PubMed ID
37839707
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.